Additionally, HDAC inhibitors promoted cell differentiation by upregulating hepatocyte-specific markers, suggesting that HDAC inhibition may play a dual role in suppressing tumor growth and inducing hepatocyte differentiation, which could have therapeutic implications for hepatocellular carcinoma treatment. This evidence concerns the gene HDAC9 and neoplasm.